Jennifer M.
About Jennifer M.
Jennifer Mintz is the Chief Revenue Officer with nearly 25 years of experience in Business Development and over 12 years in clinical research.
Chief Revenue Officer Jennifer Mintz
Jennifer Mintz holds the position of Chief Revenue Officer. In this role, she is responsible for driving revenue growth strategies and optimizing revenue streams across the organization. With extensive experience in business development and commercial operations, Mintz brings a wealth of expertise to this executive role.
Jennifer Mintz's Role at Firma Clinical Research
Before her current position, Jennifer Mintz served as Chief Commercial Officer at Firma Clinical Research. She managed key areas such as Business Development, Marketing, and Contracts and Proposals. Her leadership contributed significantly to Firma Clinical Research's commercial success and strategic growth in the clinical research industry.
Education of Jennifer Mintz
Jennifer Mintz holds a Master of Science Degree in Hospitality Administration from Johnson & Wales University. This advanced education has provided her with a strong foundation in organizational management, client services, and strategic planning, which she has effectively applied to her roles in business development and commercial operations.
Jennifer Mintz's Experience in Business Development
Jennifer Mintz has nearly 25 years of experience in Business Development. Throughout her career, she has managed business development teams in various sectors, including patient recruitment, full-service CROs (Contract Research Organizations), e-clinical technology, and decentralized trials. Her extensive experience has equipped her with deep insights into developing and executing effective business strategies in the clinical research industry.
Clinical Research Expertise of Jennifer Mintz
With over 12 years of experience in the clinical research space, Jennifer Mintz has developed significant expertise in this area. Her roles have spanned patient recruitment, full-service CROs, e-clinical technology, and decentralized trials. Her substantial experience in clinical research has enabled her to lead successfully and innovate in business development initiatives in this specialized field.